CUVLVSREGN• 12 Months (Normalized)
CUVL vs REGN (Clinuvel Pharmaceuticals Limited vs Regeneron Pharmaceuticals Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CUVL Performance $5.95
-4.03%
Clinuvel Pharmaceuticals Limited
Normalized Baseline0.00%
REGN Performance $781.49
+37.54%
Regeneron Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin REGN LEADS
-41.57%
REGN outperforming by 41.57%
CUVLREGN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CUVL REGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CUVL Price | CUVL Gain (%) | REGN Price | REGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $5.95 | -4.03% | $781.49 | +37.54% | -41.57% |
| Sep 10, 2026 | $5.88 | -5.16% | $793.26 | +39.61% | -44.77% |
| Sep 09, 2026 | $5.93 | -4.35% | $807.65 | +42.14% | -46.49% |
| Sep 08, 2026 | $6.01 | -3.06% | $810.31 | +42.61% | -45.67% |
| Sep 04, 2026 | $6.52 | +5.16% | $827.72 | +45.67% | -40.51% |
| Sep 03, 2026 | $6.28 | +1.29% | $843.47 | +48.45% | -47.16% |
| Sep 02, 2026 | $6.20 | +0.00% | $852.03 | +49.95% | -49.95% |
| Sep 01, 2026 | $- | $823.82 | +44.99% | - | |
| Aug 31, 2026 | $- | $799.08 | +40.63% | - | |
| Aug 28, 2026 | $- | $794.19 | +39.77% | - | |
| Aug 27, 2026 | $- | $807.71 | +42.15% | - | |
| Aug 26, 2026 | $- | $814.79 | +43.40% | - | |
| Aug 25, 2026 | $- | $833.56 | +46.70% | - | |
| Aug 24, 2026 | $- | $828.50 | +45.81% | - | |
| Aug 21, 2026 | $- | $834.04 | +46.79% | - |
Page 1 of 17